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The control of promoter-proximal pausing and the
release of RNA polymerase II (Pol II) is a widely
used mechanism for regulating gene expression in
metazoans, especially for genes that respond to
environmental and developmental cues. Here, we
identify that Pol-II-associated factor 1 (PAF1) pos-
sesses an evolutionarily conserved function in
metazoans in the regulation of promoter-proximal
pausing. Reduction in PAF1 levels leads to an
increased release of paused Pol II into gene bodies
at thousands of genes. PAF1 depletion results in
increased nascent and mature transcripts and
increased levels of phosphorylation of Pol II’s C-ter-
minal domain on serine 2 (Ser2P). These changes can
be explained by the recruitment of the Ser2P kinase
super elongation complex (SEC) effecting increased
release of paused Pol II into productive elongation,
thus establishing PAF1 as a regulator of promoter-
proximal pausing by Pol II.INTRODUCTION
It has long been known that a major regulatory step of transcrip-
tion by RNA Pol II activity in metazoans is the control of the
release of promoter-proximal pausing (Kwak and Lis, 2013;
Luo et al., 2012b; Peterlin and Price, 2006; Smith and Shilatifard,
2013). Stress-inducible genes such as Hsp70 in Drosophila, the
proto-oncogeneMYC, and the HIV-1 provirus, were found to be
regulated at the transition from transcription initiation by Pol II to
productive elongation (Bentley and Groudine, 1986; Gilmour and
Lis, 1986; Kao et al., 1987; Toohey and Jones, 1989). This pro-
moter-proximal pausing by Pol II is characterized by an engaged
polymerase transcribing 20–60 nt downstream of the transcrip-
tion start site (TSS) (Gilmour and Lis, 1986; Rougvie and Lis,
1988). Recently, genome-wide studies using Pol II chromatin
immunoprecipitation (ChIP-chip and ChIP-seq), nuclear run-on
(GRO-seq), and the sequencing of short transcripts demon-strated that most genes in Drosophila and mammalian cells are
characterized by a rate-limiting step of the transition of Pol II
from the initiated state to productive elongation (Levine, 2011).
In vitro transcription systems were used to identify factors that
were able to establish or release paused Pol II, including DRB
sensitivity-inducible factor (DSIF), negative elongation factor
(NELF), and positive transcription elongation factor b (P-TEFb)
(Marshall and Price, 1995; Wada et al., 1998; Yamaguchi et al.,
1999). DSIF, which consists of Spt4 and Spt5, promotes pausing
in conjunction with NELF and also serves as a factor required for
increasing the catalytic rate of transcription elongation by Pol II.
P-TEFb is a kinase that phosphorylates the C-terminal domain
(CTD) of RPB1, the largest subunit of Pol II, the C-terminal
domain of SPT5, and the NELF-E subunit to promote the transi-
tion to transcription elongation (Fujinaga et al., 2004; Marshall
et al., 1996; Yamada et al., 2006).
The RPB1 CTD contains a heptad repeat (consensus Tyr1-
Ser2-Pro3-Thr4-Ser5-Pro6-Ser7) that is subject to extensive
post-translational modifications, most notably phosphorylation
at Ser2 and Ser5 residues (Smith and Shilatifard, 2013). In
contrast to Ser5-phosphorylated Pol II (Ser5P), which peaks
around the TSS and is associated with paused Pol II, Ser2-
phophorylated Pol II (Ser2P) accumulates throughout gene
bodies and is associated with elongating Pol II. Phosphorylation
of Ser2, which is implemented by P-TEFb, is considered to be
essential for the release of paused Pol II and for productive tran-
scription elongation (Eick and Geyer, 2013; Ni et al., 2008).
Most P-TEFb in cells is sequestered in an inactive complex
with the 7SK snRNA and the proteins HEXIM1 or HEXIM2,
LARP7, and MEPCE (Zhou et al., 2012). Upon cellular signals,
P-TEFb is released from the 7SK snRNP complex, allowing it
to interact with bromodomain-containing protein 4 (BRD4) or to
incorporate into the super elongation complex (SEC) with other
transcription elongation factors such as ELL2 and AFF4 (Lin
et al., 2010; Sobhian et al., 2010; He et al., 2010; Luo et al.,
2012b). Among the three P-TEFb-containing complexes, the
most active forms were observed within the SEC family (Luo
et al., 2012a). SEC, but not BRD4, is required for the release of
paused Pol II at developmental genes in response to retinoic
acid (RA) induction (Lin et al., 2011), as well as for the Tat-medi-
ated activation of HIV-1 proviral transcription (Li et al., 2013b). ItCell 162, 1003–1015, August 27, 2015 ª2015 Elsevier Inc. 1003
was also demonstrated that the association of SEC with a given
gene and not paused Pol II is a major indication of rapid tran-
scriptional induction (Lin et al., 2011).
Although the in vitro function of P-TEFbwithin its complex SEC
has been extensively validated by in vivo studies, the function of
NELF has been more enigmatic. Studies in vitro led to a model
in which the role of NELF was to restrain Pol II in the paused
state, while in vivo studies revealed that loss of NELF led to
more downregulation of gene expression rather than upregula-
tion (Gilchrist et al., 2008). Subsequent studies demonstrated
that knockdown of NELF can lead to a global reduction of Pol
II occupancy at promoter-proximal regions (Core et al., 2012),
which can then lead to nucleosomes moving into the region to
prevent re-initiation of Pol II (Core et al., 2012). Thus, how pro-
moter-proximal paused Pol II is restrained 20–60 nt downstream
of the promoters is currently unknown.
To identify factors required for the regulated release of pro-
moter-proximal paused Pol II, we set up an RNAi screen of Pol
II elongation factors followed by Pol II ChIP-seq. Here, we report
PAF1 as being an evolutionarily conserved factor that contrib-
utes significantly to the process of pause release by Pol II.
PAF1 was originally identified biochemically as a factor co-pur-
ifying with Pol II from yeast extracts (Shi et al., 1996; Wade and
Jaehning, 1996), and the role of PAF1 and its complex, in serving
as a platform for co-transcriptional histone-modifying enzymes
and RNA-processing factors, is highly conserved from yeast to
humans (Krogan et al., 2003; Shilatifard 2006). Our studies in
mammalian cells reveal that the loss of PAF1 leads to wide-
spread release of the promoter-proximal paused Pol II into
gene bodies. The loss of PAF1 is associated with an increased
Ser2P form of Pol II and increased nascent transcription. Most
significantly, the SEC, which is required for the rapid transcrip-
tional induction and release of promoter-proximal paused Pol II
into gene bodies (Lin et al., 2010; Lin et al., 2011), is rapidly re-
cruited to Pol II upon PAF1 loss. This study reveals an evolution-
arily conserved role for PAF1 as a regulator of promoter-proximal
pausing by RNA Pol II in metazoans.
RESULTS
PAF1 Depletion Leads to a Redistribution of Pol II from
Promoters to Gene Bodies
PAF1 was identified as a factor co-purifying with RNA Pol II
(Shi et al., 1996; Wade et al., 1996), and in vitro approaches
have shown that PAF1 can facilitate transcription elongation
cooperatively with TFIIS, DSIF, and Tat-SF1 (Chen et al., 2009;
Kim et al., 2010). Furthermore, in yeast, we demonstrated that
PAF1 functions by regulating histone modifications associated
with elongating forms of Pol II (Krogan et al., 2003). To identify
factors required for the regulation of release of promoter-prox-
imal paused Pol II, we set up an RNAi screen of Pol II elongation
factors followed by Pol II ChIP-seq. Our screen identified a role
for PAF1 in this process. Pol II ChIP-seq following PAF1 deple-
tion using two independent short hairpin RNAs (shRNA) targeting
PAF1 (shPAF1#1 and shPAF1#2) in HCT116 cells was performed
(Figure 1A). For many genes, exemplified by RHOB, DKK1, and
PHLDA2, reduction in PAF1 levels leads to an increase of Pol II
within gene bodies (Figure 1B). To examine whether this type1004 Cell 162, 1003–1015, August 27, 2015 ª2015 Elsevier Inc.of change in the Pol II pattern is a general occurrence,
genome-wide analysis was applied to genes occupied by Pol II
in the control condition, as defined by having a peak called by
MACS (model-based analysis of ChIP-seq) (Zhang et al., 2008)
overlapping the region from the TSS to 500 bp downstream of
the TSS, and this region having reads permillion (rpm) > 1. Genes
also had to be >2 kb in length and >1 kb from any other gene in
order to be considered for analysis. As shown in a plot of average
gene occupancy of the resulting 9,333 genes, the increase of Pol
II within gene bodies after PAF1 knockdown is observed for both
shRNAs targeting PAF1 (Figures 1C and S1A), suggesting that
PAF1 has a genome-wide role in controlling the procession of
Pol II into gene bodies.
PAF1 has a Broad Role in the Maintenance of
Promoter-Proximal Pol II Pausing
Genome-wide studies in Drosophila and mammals have shown
that Pol II accumulates at the 50 end of most genes and collec-
tively is referred to as promoter-proximal pausing. The preva-
lence of Pol II pausing in metazoans rather than yeast implies
that Pol II release after recruitment at promoters is an essential
step of transcription regulation in higher organisms (Kwak and
Lis, 2013; Smith and Shilatifard, 2013). The observed changes
in the Pol II pattern after PAF1 depletion suggest defects in
Pol II pausing control. To verify this, we calculated the ratio of
Pol II occupancy between the gene body and its promoter (Fig-
ure 1D), a modified traveling ratio or body/promoter calculation
(Core et al., 2008; Reppas et al., 2006; Thornton et al., 2014)
that for convenience we refer to as the ‘‘Pol II release ratio’’
(PRR). Specifically, the promoter is defined as 100 bp upstream
and 300 bp downstream of the TSS, and the gene body is
defined as the region from 300 bp to 2 kb downstream of the
TSS. These regions were chosen to measure the release of Pol
II from promoters while avoiding complications from potential
roles of PAF1 in Pol II processivity in gene bodies and in tran-
scription termination. Correlations of PRR fold change (PRR_FC)
between biological replicates (Figure S1B) and between inde-
pendent shRNAs targeting PAF1 (Figure S1C) reveal a consistent
role of PAF1 in controlling Pol II pausing.
We calculated the degree of overlap of genes showing
increased PRR values (PRR_FC > 1) following PAF1 depletion
by two independent shRNAs (Figure S1D). shPAF1#1, which is
more efficient for depleting PAF1 levels (Figure 1A), leads to a
larger number of genes exhibiting an increased PRR value
(5,112 versus 3,420). However, 84.7% (2,897 of 3,420) of genes
with increased PRR values after PAF1 depletion using the less
efficient shPAF1#2 are also affected by shPAF1#1, indicating
that the phenomenon of increased PRR is due to PAF1 depletion.
Therefore, subsequent analysis was restricted to the stronger
shPAF1#1 (abbreviated as shPAF1 hereafter). An empirical cu-
mulative distribution function (ECDF) plot reveals that 90% of
genes have a PRR value <0.5 (log2 [PRR] < 1), indicating the
prevalence of promoter-proximal pausing regulation (Figure 1E).
The knockdown of PAF1 leads to a significant increase (Kolmo-
gorov-Smirnov test of distributions, p < 2.2e-16, D value =
0.2664) of PRR values on average (Figures 1E and S1E).
In order to ask whether the increased Pol II in gene bodies was
due to a general amplification in transcription as opposed to
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Figure 1. Depletion of PAF1 Results in a
Redistribution of Pol II from Promoters to
Gene Bodies
(A) Cells transduced with shScr or two indepen-
dent shRNAs targeting PAF1 (shPAF1#1 and
shPAF1#2) were subjected to western blotting with
antibodies against PAF1 and b-tubulin.
(B) Representative genome browser track exam-
ples of total Pol II ChIP-seq in HCT116 cells
transduced with shScr or shPAF1#1 for the
indicated genes. The x-axis indicates the chro-
mosome position, and the y-axis represents
normalized read density in reads per million (rpm).
(C) Metagene analysis showing total Pol II occu-
pancy measured by ChIP-seq in cells transduced
with shScr or shPAF1#1. The 9,333 genes included
for analysis meet the criteria of having Pol II
(rpm > 1) at promoters in the control condition, are
longer than 2 kb, and do not have nearby genes
within 1 kb to avoid the inclusion of reads for Pol II
from nearby genes.
(D) Schematic representation of the modified
traveling ratio or body/promoter ratio used to
calculate the Pol II release ratio (herein called the
PRR). The promoter is defined as the region
covering 100 bp upstream to 300 bp downstream
of the TSS; the gene body is defined as the region
from 300 bp to 2 kb downstream of the TSS.
(E) The empirical cumulative distribution function
(ECDF) plot of the PRR distribution in cells trans-
duced with shScr or shPAF1.
(F) Track examples of total Pol II ChIP-seq in cells
transduced with shScr or shPAF1 in starved
(serum) or serum-induced (+ serum) conditions
for the indicated genes.
(G) Heatmaps of Pol II, PAF1, and LEO1 occu-
pancy around the TSS region. Rows are sorted by
decreasing Pol II occupancy in the –2 kb to +4 kb
region. Color-scaled intensities are in units of rpm.release of promoter-proximal paused Pol II, we performed Pol II
ChIP-seq in serum-starved HCT116 cells that had been trans-
duced with shScr or shPAF1. During serum starvation, genes
such as ZFP36 and FOSL1 are highly paused (Donner et al.,
2010; Lin et al., 2011). However, in the PAF1 knockdown,
increased Pol II can be seen throughout the gene body of each
of these genes, sometimes to the level of release obtained with
30 min of serum stimulation in the shScr HCT116 cells
(Figure 1F).
In order to determine whether PAF1 has a direct effect on
the regulation of Pol II at the promoter-proximal region,
ChIP-seq was performed. Heatmaps ranked by decreasing
Pol II occupancy show a positive correlation with PAF1 and
Pol II (Figure 1G). To corroborate these findings, we also per-
formed ChIP-seq with LEO1, as this was the only other anti-
body that we tested that gave any significant ChIP-seq signal.
Like PAF1, LEO1 is found throughout gene bodies, with partic-Cell 162, 1003–1015,ular enrichment around the TSS (Fig-
ure 1G). Interestingly, LEO1 was not
broadly lost from chromatin upon PAF1
knockdown, but the distribution wasaltered, including reduced occupancy in the promoter-prox-
imal region (Figure S1F).
Highly Paused Genes Are More Affected by the Loss
of PAF1
There are many degrees of Pol II pausing, with some genes such
as Drosophila Hsp70 exhibiting a rare release of Pol II into gene
bodies, while at other genes, such as b-actin, Pol II pauses briefly
before being released into gene bodies (Boehm et al., 2003;
Chen et al., 2015). In order to determine whether PAF1’s effect
on the redistribution of Pol II is related to pausing, we separated
the 9,333 genes into three groups based on the previously
described pausing index, the ratio of Pol II density at the pro-
moter over Pol II in gene bodies (Core et al., 2008; Muse et al.,
2007; Reppas et al., 2006). We calculated the PRR_FC following
PAF1 knockdown for each class of genes. We find that the highly
paused genes have the largest increase in PRR_FC valuesAugust 27, 2015 ª2015 Elsevier Inc. 1005
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Effect on Genes that Are Highly Paused
(A) Boxplot analysis of PRR fold change (PRR_FC)
after PAF1 depletion for genes with different de-
grees of pausing, as measured by pausing index
(the ratio of Pol II occupancy at promoters to oc-
cupancy over gene bodies). The 9,333 genes were
divided into three groups: highly paused (pausing
index > 4; n = 4,184), moderately paused (1 <
pausing index < 4; n = 4,743), and non-paused
(pausing index < 1; n = 406). PRR values were then
plotted in pausing index groups, and p values were
then calculated with a two-sided t test.
(B) ECDF plots of PRR for more affected (group I)
and less affected (group II) genes in cells trans-
duced with shScr or shPAF1. Group I constitutes
4,855 genes with a >1.5 increase of PRR_FC (log2
[PRR_FC] > 0.585). Group II constitutes 4,106
genes with a PRR_FC <1.5 in either direction
(0.585 > log2 [PRR_FC] > 0.585).
(C) Heatmaps of Pol II occupancy within the gene
body regions, 300 bp to 2 kb downstream of the
TSS, in cells transduced with shScr or shPAF1.
Rows are sorted by decreasing Pol II occupancy
in the shScr condition. Color-scaled intensities are
in units of rpm. For the heatmaps of fold changes
(Pol II_FC), the color bars depict log2 values.(median value: 1.82), and the non-paused genes have the small-
est change (median value: 0.98) (Figures 2A and S2A), indicating
that highly paused genes have a strong dependence on PAF1 in
maintaining Pol II pausing.
To further investigate the differential response to PAF1, genes
were classified intomore affected and less affected genes based
on the fold change of PRR after PAF1 knockdown. We found that
4,855 genes show a >1.5-fold increase of PRR_FC (log2
[PRR_FC] > 0.585), which we refer to as group I, while 4,106
genes have a <1.5-fold change of PRR_FC (0.585 > log2
[PRR_FC] > 0.585) and are referred to as group II. Only 372
genes exhibit a >1.5-fold decrease in PRR_FC, and these genes
are not considered for further analysis. ECDF plots illustrate that
group I genes are more affected than group II genes by loss of
PAF1 (Figures 2B and S2B). Heatmaps and metagene plots
reveal that group I genes have both a higher occupancy of Pol
II at promoters in the control condition and a greater increase
of Pol II within gene bodies after PAF1 knockdown (Figures 2C
and S2C). Consistent with the higher level of Pol II at group I1006 Cell 162, 1003–1015, August 27, 2015 ª2015 Elsevier Inc.genes, higher occupancy for PAF1 at
group I genes is observed (Figure S2D).
Pol II Release due to PAF1 RNAi
Generates Increased Nascent and
Mature Transcripts
The increased levels of Pol II found in gene
bodies after PAF1RNAi could conceivably
be explained byPol II getting stuck in gene
bodies due to arrest or backtracking of Pol
II resulting from loss of an elongation ac-
tivity of PAF1 or associated factors. Toaddress this question, we performed global run-on sequencing
(GRO-seq) in control andPAF1 shRNA-treated cells (Figure S3A).
GRO-seq measures the level and location of engaged polymer-
ases, but not arrested or backtracked polymerases, on a gene
at the time of nuclear isolation (Core et al., 2008). The genes
shown in Figure 1B, with increased Pol II in gene bodies after
PAF1 knockdown, also exhibit increased gene body GRO-seq
signal (Figure 3A). This increase inGRO-seq signal in genebodies
can also be observed bymetagene analysis (Figure 3B). The PRR
calculations based on GRO-seq signal demonstrate a significant
increase (D value = 0.2528) of PRR following PAF1 knockdown
(Figure 3C), further demonstrating a global defect in pausing con-
trol. Heatmap and metagene analyses of GRO-seq signal were
broken out by group I and group II genes, with group I exhibiting
a more significant increase of nascent RNA within gene bodies
(Figures 3D and S3B).
As a complementary approach to GRO-seq, we also per-
formed nascent RNA-seq in control and PAF1-depleted cells.
NascentRNA-seq takes advantage of the high affinity of engaged
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Figure 3. Pause Release following PAF1
Depletion Represented by GRO-Seq
(A) Genome browser tracks of GRO-seq in cells
transduced with shScr or shPAF1 for the same set
of genes shown in Figure 1B. Positive and negative
values on the y-axis represent normalized reads
(rpm) mapping to the positive and negative
strands, respectively.
(B) Metagene analysis showing Pol II occupancy
as measured by GRO-seq in cells transduced with
shScr or shPAF1.
(C) Boxplots of log2 PRR values of GRO-seq signal
in cells transduced with shScr or shPAF1.
(D) Heatmaps of GRO-seq signal around TSS
regions in cells transduced with shScr or shPAF1
for group I and group II genes. Rows are sorted
by decreasing Pol II occupancy in the –2 kb to +4
kb region in the shScr condition. Color-scaled
intensities are in units of rpm.Pol II with DNA and associated nascent transcripts to wash away
mature RNA before performing RNA extraction (Khodor et al.,
2011). High correlations between replicates indicate the repro-
ducibility of nascent RNA-seq (Figures 4A and S4A). Genes
shown in Figures 1B and 3A, with increased Pol II in gene bodies
after PAF1 knockdown, also exhibit increased nascent tran-
scripts (Figure 4A). Since increased levels of nascent transcripts
could reflect more transient pausing of Pol II in gene bodies, we
also performed total RNA-seq after PAF1 knockdown (Figures
4B and S4B). By comparing group I genes with group II genes
for changes in GRO-seq, nascent-seq or total RNA-seq, we
observed that group I genes generally had higher levels of
nascent and mature transcripts after PAF1 RNAi, while group II
genes were downregulated (Figures 4C–4E). Hierarchical clus-
tering demonstrates that GRO-seq, nascent-seq, and total
RNA-seq show similar changes in expression after PAF1 knock-
down (Figure 4F). Importantly, by all three measures, we
observed that group I genes were more likely to show increased
expression, while group II genes were more likely to be downre-
gulated (Figure S4C). Therefore, since the total RNA-seq anal-
ysis, which is primarily a measure of mature stable transcripts,
concurs with the Gro-seq and nascent RNA-seq results, weCell 162, 1003–1015,can conclude that the observed increase
of Pol II in gene bodies for group I genes
isdue tomore releaseofPol II intoproduc-
tive elongation.
Pausing Regulation by PAF1 and
H2B Monoubiquitination
In an attempt todetermine themechanism
by which PAF1 loss led to the release
of paused Pol II, we considered PAF1’s
role in promoting the monoubiquitination
of histone H2B at lysine 120 (H2Bub)
by directly interacting with the RAD6-
BRE1A/B, E2-E3, ubiquitin ligases that
implement H2Bub (Wood et al., 2003a;
Krogan et al., 2003). To evaluate the rela-tionshipbetweenPAF1-dependentH2Buband theeffect of PAF1
on pausing, we performedH2BubChIP-seq in control and PAF1-
depleted cells. Heatmaps reveal that the H2Bub levels are much
higher in group I than in group II (Figure S5A, compare columns 1
and 4), suggesting that group I genes aremore highly transcribed
than group II genes, as H2Bub levels correlate with transcription
levels (Lee et al., 2012; Minsky et al., 2008; Krogan et al., 2003).
However, the decrease of H2Bub appears equally evident
for both groups I and II (Figure S5A, compare columns 3 and 6),
indicating that changes in H2Bub may not simply explain the
observed changes in the Pol II distribution seen after PAF1 RNAi.
To directly test the link between H2Bub and promoter-prox-
imal Pol II pausing, ChIP-seq of total Pol II was performed in cells
transduced with either control or BRE1A shRNAs. We originally
discovered Bre1 in yeast as the E3 ligase required for H2Bmono-
ubiquitination and H3K4 trimethylation (Wood et al., 2003b). In
mammalian cells, Bre1 functions within both Bre1A and Bre1B
genes (Wood et al., 2003b; Shilatifard, 2012). Western analysis
shows efficient knockdown of BRE1A for two independent
shRNAs. Although PAF1 depletion does not affect the bulk level
of BRE1A, knockdown of either BRE1A or PAF1 results in a bulk
loss of H2Bub (Figure 5A). However, ECDF and metageneAugust 27, 2015 ª2015 Elsevier Inc. 1007
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Figure 4. PAF1 Depletion Leads to Deregu-
lation of Gene Expression
(A and B) Genome browser tracks of nascent RNA-
seq (A) and total RNA-seq (B) in cells transduced
with shScr or shPAF1 for the same set of genes
shown in Figure 1B. Positive and negative values
on the y-axis represent normalized reads (rpm)
mapping to the positive and negative strands,
respectively.
(C–E) Boxplots showing the log2 fold change of
RNA levels from GRO-seq (C), nascent RNA-seq
(D), and total RNA-seq (E) following the knock-
down of PAF1 in groups I and II.
(F) Hierarchical clustering demonstrating similar-
ities in the log2 fold changes of RNA levels as
determined by GRO-seq, nascent RNA-seq, and
total RNA-seq following PAF1 depletion.analyses demonstrate that BRE1A knockdown does not result in
a major redistribution of Pol II, as seen with PAF1 depletion when
comparing all genes (Figures S5B and S5C) or when comparing
group I and group II genes (Figure 5B).
PAF1 as a Negative Regulatory Factor for CTD
Phosphorylation
To further substantiate that the increased Pol II in gene bodies in
PAF1 knockdown cells is due to the release of paused Pol II into
the elongating form, we measured the levels of Pol II CTD phos-
phorylation at serine 2 (Ser2P), the elongating form of Pol II, by
western blotting and ChIP-seq in cells transduced with shScr
or shPAF1. Western analysis indicates that PAF1 has no effect
on the bulk levels of Ser2P or on total Pol II levels (Figure 5C).
However, measuring the ratio of Ser2P to total Pol II shows
that the relative levels of Ser2P to total Pol II are increased at pro-
moters of group I genes, but not group II genes (Figure 5D). Heat-
maps and metagene analysis of Ser2P occupancy indicate that1008 Cell 162, 1003–1015, August 27, 2015 ª2015 Elsevier Inc.this is a widespread phenomenon, with
group I genes exhibiting a greater in-
crease of Ser2P at promoters and in
gene bodies (Figures 5E and 5F).
PAF1 Regulates CTD
Phosphorylation through the
Recruitment of SEC
To determine whether the increased
release of paused Pol II into gene bodies
is due to increased recruitment of SEC
containing the most active version of
P-TEFb that phosphorylates serine 2 of
the RPB1 CTD to release Pol II from the
paused state (Lin et al., 2010; Luo et al.,
2012a, 2012b), we performed ChIP-seq
of the SEC subunits AFF4, ELL2, and
CDK9 in cells transduced with shScr
or shPAF1. Western blotting shows that
PAF1 depletion does not affect the global
protein levels for AFF4, ELL2, or CDK9
(Figure 6A). However, at those geneswith increased PRR, such as RHOB, DKK1, and PHLDA2, the
levels of SEC subunits are increased (Figure 6B). Metagene
and heatmap analyses demonstrate that increased SEC occu-
pancy following knockdown of PAF1 is a widespread occurrence
(Figures 6C–6E and S6A–6C). Furthermore, analyses of group I
and group II genes demonstrate that SEC occupancy is
increasedmore at group I genes, and this increase occurs at pro-
moter-proximal regions and, to a lesser extent, in gene bodies
(Figures 6F–6H). Consistent with an increase in the release of
Pol II in PAF1 knockdowns occurring through P-TEFb activity,
treatment with the P-TEFb inhibitor flavopiridol (FP) resulted
in restoration of the paused state in PAF1 knockdown cells
(Figure S6D).
Functional Conservation of Pausing Maintenance by
PAF1 in Drosophila and Mammals
To rule out the possibility that PAF1-dependent regulation of
pausing is a cell-type-specific occurrence, ChIP-seq of total
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Figure 5. Changes in CTD Phosphorylation, but Not H2B Monoubiquitination, Are Associated with the Release of Pol II into Gene Bodies in
PAF1-Depleted Cells
(A) Cells transduced with shScr, shPAF1, or two independent shRNAs targeting BRE1A (shBRE1A#1 and shBRE1A#2) were subjected to western blotting with
antibodies against H2Bub, BRE1A, PAF1, and b-tubulin.
(B) ECDF plots of the PRR distributions in cells transduced with shScr or shBRE1A#1 for group I and group II.
(C) Western blotting with antibodies against total Pol II (N20), Ser2P (3E10), and b-tubulin for cells transduced with shScr or shPAF1.
(D) Boxplots showing the ratio of Ser2P and total Pol II at promoters for group I and group II genes.
(E) Heatmaps of Ser2P levels around TSS regions in cells transducedwith shScr or shPAF1 for all genes. Rows are sorted by decreasing Pol II occupancy in the –2
kb to +4 kb region in the shScr condition. Color-scaled intensities are in units of rpm. For the heatmaps of fold changes (Ser2P_FC), the color bars depict log2
values.
(F) Metagene analysis showing average Ser2P occupancy as measured by ChIP-seq in cells transduced with shScr or shPAF1 for group I and group II genes.Pol II in MCF7 cells was performed. We found a similar increase
in pause release as seen in HCT116 cells (Figure 7A). As repre-
sented by PRR_FC, the highly paused genes have the largest de-
gree in pause release, while the non-paused genes show the
least change (Figure 7B). Therefore, PAF1’s role in the regulation
of pausing is likely to be widespread.
Pol II pausing is also pervasive in Drosophila, especially for
genes involved in the response to environmental and develop-
mental cues. To investigate whether pausing maintenance by
PAF1 is conserved in Drosophila, ChIP-seq of Rpb1, the largest
subunit of Pol II, was performed in control and Paf1 RNAi S2cells. We found that the increased release of paused Pol II
was also observed for a subset of genes in Drosophila, as
exemplified by foi, CG14629, CG1572, and CG6231 (Figure 7C).
The PRR values were calculated for genes grouped by different
degrees of pausing as measured by the pausing index. As
observed in mammalian cells, highly paused genes displayed
a significant increase in pause release after Paf1 RNAi (Figures
7D), indicating a conserved role of Paf1 in regulating the release
of Pol II from promoter-proximal pausing. Together, these find-
ings suggest that the increased recruitment of SEC by PAF1
depletion is responsible for the enhanced phosphorylation ofCell 162, 1003–1015, August 27, 2015 ª2015 Elsevier Inc. 1009
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Figure 6. PAF1 Regulates CTD Phosphorylation of Elongating Pol II through Recruitment of SEC
(A) Western blotting with antibodies against SEC subunits (CDK9, AFF4, and ELL2) and b-tubulin for cells transduced with shScr or shPAF1.
(B) Track examples of AFF4, ELL2, and CDK9 occupancy in cells transduced with shScr or shPAF1 for the same set of genes shown in Figure 1B.
(C–E) Heatmaps of AFF4 (C), ELL2 (D), and CDK9 (E) levels around TSS regions in cells transduced with shScr or shPAF1 for all genes. Rows are sorted by
decreasing Pol II occupancy in the –2 kb to +4 kb region in the shScr condition. Color-scaled intensities are in units of rpm.
(F–H) Metagene analyses showing the occupancies of AFF4 (F), ELL2 (G), and CDK9 (H) as measured by ChIP-seq in cells transduced with shScr or shPAF1.
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Pol II and for its release into transcription elongation (Figures 7E
and 7F).
DISCUSSION
In vitro studies had previously identified factors promoting
pausing, including NELF, DSIF, and GDOWN1 (Smith and Shila-
tifard, 2013). DSIF and NELF cooperate to establish pausing
in vitro (Yamaguchi et al., 1999), but since DSIF has a second
role as an essential factor for processive transcription (Swanson
et al., 1991; Wada et al., 1998), most attention has focused on
NELF as the key factor for themaintenance of Pol II in the paused
state. However, knockdown of NELF in cells led to more
genes with decreased than increased expression when assayed
with gene expression microarrays (Gilchrist et al., 2008). More
recently, GRO-seq was used to demonstrate that, while knock-
down of NELF leads to significant reductions in occupancy of
promoter-proximal Pol II at a large number of genes, the nascent
Pol II in gene bodies was also reduced (Core et al., 2012). Thus,
loss of NELF does not lead to a release of paused Pol II into gene
bodies, even though NELF has a clear role in the establishment
of Pol II at promoters of paused genes (Core et al., 2012; Li
et al., 2013a).
The PAF1 complex (PAF1C) has a well-established role as a
factor promoting transcription elongation in vitro (Wood et al.,
2003a; Krogan et al., 2003; Chen et al., 2009; Kim et al., 2010;
Pavri et al., 2006). The in vivo evidence for PAF1C facilitating
transcription elongation largely consists of the PAF1C-depen-
dent histone modifications such as H2Bub, H3K4me3, and
H3K79me3 that occur subsequent to transcriptional activation,
as well as defects in RNA processing that could be downstream
consequences of the PAF1C-dependent histone modifications
(Krogan et al., 2003; Jaehning, 2010; Shilatifard, 2006; Sims
et al., 2004). Our studies suggest that the effects on Pol II release
into gene bodies after PAF1 knockdown cannot simply be ex-
plained by changes in histone H2B monoubiquitination levels
(Figures 5 and S5). In addition to a role for Paf1 complex in the
regulation of H2B monoubqiuitination levels, our previous
studies demonstrated that Paf1 complex in yeast is also required
for proper H3K36methylation by yeast Set2 (Krogan et al., 2003).
There are several Set2-related factors in human cells, including
Set2, ASH1, NSD1, NSD2, and NSD3. A possible role for these
factors individually or collectively in the regulation of Pol II
pausing through PAF1 should also be considered.
Most in vivo studies of PAF1C function have been performed in
yeast, which lack promoter proximal pausing as seen in meta-
zoans. Yeast also lack NELF and SEC, factors involved in setting
up pausing and facilitating pause release, respectively. Nonethe-
less, biochemical and genetic studies in yeast have provided us
with the idea of PAF1C being a platform for interactions with
numerous factors connecting its function to multiple transcrip-
tional processes, from transcription elongation to transcription
termination (Jaehning, 2010; Krogan et al., 2002; Shilatifard,
2006; Krogan et al., 2003). Therefore, it is not surprising that
PAF1C in metazoans would have additional roles in regulating
promoter-proximal pausing.
The increase in SEC recruitment observed after PAF1 deple-
tion suggests that the presence of PAF1 restricts access toSEC in some manner (Figure 6). This could occur through inter-
actions between PAF1 and Pol II and/or associated factors
that occlude binding surfaces for SEC. Under this scenario,
upon removal of PAF1, SEC can find its phosphorylation sub-
strates on the Pol II and SPT5 CTDs, leading to more Pol II
release into gene bodies. Under normal activating conditions,
signaling pathways could communicate through PAF1 to allow
access to SEC, after which both PAF1C and SEC can participate
in transcription elongation and associated processes.
In the past few years, several factors with known roles in tran-
scription termination—namely, XRN2, TTF2, and the Integrator
complex—have been linked to the control of promoter-proximal
pausing (Gardini et al., 2014; Stadelmayer et al., 2014). Inter-
estingly, Gdown1 can inhibit the termination activity of TTF2
in vitro, and loss of Gdown1 leads to decreased promoter-prox-
imal Pol II and increased Pol II in gene bodies (Cheng et al.,
2012). Since PAF1C has known roles in transcription termination
(Crisucci and Arndt, 2011), it is possible that PAF1 interacts with
termination machineries at promoter-proximal regions to help
regulate the paused Pol II state. However, whether there is wide-
spread terminationofPol II inpromoter-proximal regions is still un-
der debate (Jonkers and Lis, 2015). An interesting area for future
investigation will be to determine to what extent some of these
factors work together at the same genes and respond to the
same cellular signals. Nonetheless, these studies emphasize the
need for in vivo functional approaches to screen for factors,which
caneithercomplementor extend the in vitroapproaches that have
dominated studies of promoter-proximal pausing in metazoans.
EXPERIMENTAL PROCEDURES
Additional details on ChIP-seq, nascent and total RNA-seq, and Gro-seq can
be found in the Supplemental Experimental Procedures.
Antibodies
Human Pol II (N-20) and CDK9 (C-20) antibodies for ChIP-seq were purchased
from Santa Cruz, anti-PAF1 (ab137519) was from Abcam, anti-LEO1 (A300-
175A) was from Bethyl Laboratories, anti-H2Bub (mAb #5546) and anti-
BRE1A (mAb #9425) were from Cell Signaling, and anti-Ser2P (3E10) was
from Millipore. Anti-CDK9 (Figure 6A), anti-AFF4, anti-ELL2, and anti-
Drosophila Rpb1 were made in house and were previously described (Lin
et al., 2010, 2011). Anti-b-tubulin E7 monoclonal antibody was purchased
from the Developmental Hybridoma Studies Bank.
Cell Lines and RNA Interference
HCT116 and MCF7 cells were grown in DMEM supplemented with 10% FBS.
The cells were infected with lentivirus containing short-hairpin RNAs in the
presence of 8 mg/ml Polybrene (Sigma) for 24 hr in DMEM supplemented
with 10% FBS. The infected cells were selected with 2 mg/ml puromycin
for an extra 48 hr before harvest. The shRNAs were purchased from Open
Biosystems. The clone IDs for shPAF1 are TRCN0000010939 (#1) and
TRCN0000005454 (#2). The clone IDs for shBRE1A are TRCN0000033875
(#1) and TRCN0000033877 (#2).
For serum starvation experiments, HCT116 cells were transduced with
shScr or shPAF1, and then 24 hr later, cells were serum starved for 48 hr.
For serum stimulation, starved cells transduced with shScr were fed back
DMEM supplemented with 10% FBS for 30 min.
For flavopiridol inhibition of pause release, HCT116 cells transduced with
shPAF1 for 3 days were treated with 1 mM flavopiridol (Sigma) for 30 min.
S2 cells were maintained at 2-10e6 cells/ml in SFX medium (containing 1%
penicillin/streptomycin) and were incubated at 28C prior to RNAi treatment.
Cells were plated at 5e5 cells/ml in 20 ml SFX per T75 flask and were treatedCell 162, 1003–1015, August 27, 2015 ª2015 Elsevier Inc. 1011
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Figure 7. The Role of PAF1 in Regulating Pol II Pausing in Metazoans
(A) Track examples of total Pol II ChIP-seq in MCF7 cells transduced with shScr or shPAF1 for the indicated genes.
(B) Boxplot analysis of PRR fold change (PRR_FC) after PAF1 depletion for genes with different degrees of pausing asmeasured by pausing index (the ratio of Pol
II occupancy at promoters to occupancy over gene bodies) in MCF7 cells.
(C) Track examples of total Pol II ChIP-seq in Drosophila S2 cells with non-targeting (LacZ) or Paf1 RNAi for the indicated genes.
(D) Boxplot analysis of PRR fold change (PRR_FC) after PAF1 depletion by dsRNA#1 targeting Paf1 for genes with different degrees of pausing as measured by
pausing index (the ratio of the Pol II occupancy at promoters to the occupancy over gene bodies). Genes that have Pol II (rpm > 1) at promoters in the control
condition, are longer than 1 kb, and do not have nearby genes within 200 bp were selected and then divided into three groups: highly paused (pausing index >10;
(legend continued on next page)
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with 100 mg dsRNA for 5.5 days. dsRNA was generated using T7 RiboMAX
Large Scale RNA Production Kit (Promega). Oligonucleotide sequences are
available in the Supplemental Experimental Procedures.
ChIP-Seq
53 107 cells were used for each ChIP assay, as described (Chen et al., 2015;
Lee et al., 2006). ChIP-sequencing libraries were prepared with Illumina’s Tru-
seq DNA sample prep kit.
Nascent RNA-Seq
The nascent RNA isolation procedure was previously described (Chen et al.,
2015; Khodor et al., 2011). Libraries were made with the TruSeq RNA sample
Prep Kit (Illumina).
Gro-Seq
The global nuclear run-on procedure and the preparation of Gro-seq libraries
were previously described (Core et al., 2008; Gardini et al., 2014).
ChIP-Seq Analysis
ChIP-seq reads were aligned to the human genome (UCSC hg19) for HCT116
and MCF7 cells and the Drosophila genome (UCSC dm3) for S2 cells, using
Bowtie version 1.0.0 (Langmead et al., 2009). Only uniquely mapping reads
with up to twomismatches within the entire length of the read were considered
for further analysis. The resulting readswere extended to 150 bases toward the
interior of the sequenced fragment and were normalized to total reads aligned
(reads per million, rpm). Peak detection for Pol II was done with MACS (model-
based analysis of ChIP-Seq) (Zhang et al., 2008) version 1.4.2 using default
parameters. Gene annotations and transcript start site information for human
and Drosophila genes were from Ensembl release 72.
Total Pol II ChIP-Seq analysis
Genes considered for analysis had peaks of Pol II with p < 1e-5 in the scram-
bled short-hairpin control condition (shScr) or dsLacZ for human orDrosophila,
respectively. For human data, the peaks had to overlap the transcription start
site (TSS) (from the TSS to 500 bp downstream of the TSS), and the reads per
million (rpm) had to be >1 for the same window, and genes had to be >2 kb in
length and be >1 kb from neighboring genes to avoid potential artifacts of
analyzing reads from nearby gene promoters or transcription termination sites
(TTS). For genes with multiple TSS’s only the highest occupied was used. For
Drosophila data, genes had to be >1 kb in length and >200 bp from neigh-
boring genes.
Promoter release ratios (PRR) were calculated for the resulting 9,333 genes
by taking the average coverage in rpm in the gene body (300 bp downstream of
the TSS to 2 kb downstreamof the TSS) divided by the average coverage of the
promoter region (100 upstream of the TSS to 300 downstream of the TSS).
Genes were then placed into two groups based on the fold change of PRR
values (PRR_FC). Group I (more affected) genes had a PRR_FC >1.5-fold
(n = 4,855); group II (less affected) genes had a PRR_FC <1.5 fold in either
direction (n = 4,106); 372 genes had a >1.5 fold decrease of PRR_FC (p values
were then calculated with a two-sided Kolmogorov-Smirnov test). The percent
overlap was calculated for shRNA replicates by taking the common peaks
for shScr in both batches that overlapped the TSS (TSS to 500 bp down-
stream, 7,354 peaks) and finding intersecting genes with a PRR _FC > 1
(log2 [PRR_FC] > 0).
ACCESSION NUMBERS
ChIP-seq, RNA-seq, and Gro-seq data are available at GEO under accession
number GEO: GSE70408.n = 1,003), moderately paused (2 < pausing index < 10; n = 3,089), and non-paus
groups, and p values were then calculated with a two-sided t test.
(E) In metazoans, Pol II is frequently found to be pausing near the promoter and is p
bodies is restrained by PAF1, a component of the PAF complex, which is recruit
(F) Upon depletion of PAF1, the CTD kinase SEC is recruited and subsequently pho
paused Pol II into productive elongation.SUPPLEMENTAL INFORMATION
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